5 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Recruiting 5 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis Avacopan, prednisolone and rituximab, Prednisolone and rituximab - ANCA Associated Vasculitis (AAV) | Phase 4 | Recruiting | Chiba University | 160 | 2024-11-15 | 2025-05-04 |
| A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis Avacopan, Placebo, Standard of Care - Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 4 | Recruiting | Amgen | 300 | 2024-02-07 | 2026-09-30 |
| Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM) Telitacicept, Placebo of Telitacicept - ANCA Associated Vasculitis | Phase 4 | Recruiting | Chinese SLE Treatment And Research Group | 40 | 2023-06-29 | 2023-07-27 |
| Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM) Azathioprine, Telitacicept - ANCA-associated Vasculitis, Maintenance Therapy | Phase 4 | Recruiting | Chinese SLE Treatment And Research Group | 40 | 2023-03-09 | 2023-07-28 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (4) · Granulomatosis with Polyangiitis (2) · Microscopic Polyangiitis (2) · Antiphospholipid Syndrome (1) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Arthritis, Rheumatoid (1) · Axial Spondyloarthritis (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Scleroderma, Systemic (1) · Takayasu Arteritis (1)
Autoimmune Diseases (5) · Cardiovascular Diseases (5) · Immune System Diseases (5) · Skin Diseases (5) · Skin Diseases, Vascular (5) · Skin and Connective Tissue Diseases (5) · Vascular Diseases (5) · Vasculitis (5) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebral Small Vessel Diseases (2) · Cerebrovascular Disorders (2) · Lung Diseases (2) · Lung Diseases, Interstitial (2)
avacopan (2) · telitacicept (2) · Azathioprine (1) · Prednisolone (1) · Rituximab (1) · Standard of Care (1) · Vaccines (1)
Chinese SLE Treatment And Research Group (2) · Amgen (1) · Chiba University (1) · University of Sao Paulo General Hospital (1)
China (2) · Brazil (1) · Czechia (1) · Denmark (1) · Greece (1) · Hungary (1) · Japan (1) · Poland (1) · Romania (1) · United States (1)
JIng Li, M.D. (1) · Jing Li, MD (1) · Masayoshi Harigai, MD, PhD (1)
PMID 19054820, PMID 23045170, PMID 33596356, PMID 34061144, PMID 35110332, PMID 35110333, PMID 36927642, PMID 9041949